Pure hypercholesterolemia is a condition where your blood has abnormally high levels of LDL cholesterol, the type that builds up in artery walls, without a corresponding rise in triglycerides. It’s classified under the ICD code E78.0 and includes both inherited (familial) and lifestyle-driven forms. The “pure” label distinguishes it from mixed conditions where multiple blood fats are elevated at once. Left untreated, it significantly raises your risk of heart attack and stroke, but early detection and treatment can reduce that cardiovascular risk by roughly 80%.
What Makes It “Pure”
Blood lipid disorders come in several varieties. Some involve high triglycerides, some involve a combination of elevated triglycerides and cholesterol, and some involve only cholesterol. Pure hypercholesterolemia falls into the last category. Your total and LDL cholesterol are elevated while triglycerides remain in the normal range. This matters because the underlying causes, health risks, and treatment approach differ depending on which blood fats are out of balance.
In clinical terms, LDL levels at or above 190 mg/dL are considered severely elevated and almost always warrant treatment. Levels between 160 and 189 mg/dL may also require medication depending on other risk factors like age, diabetes, and smoking history.
Genetic vs. Lifestyle Causes
Pure hypercholesterolemia can be inherited or acquired. The inherited form, called familial hypercholesterolemia (FH), is one of the most common genetic disorders, affecting roughly 1 in 250 people worldwide. It’s caused by mutations in genes that control how your body clears LDL from the bloodstream. The most frequently involved gene codes for the LDL receptor, which sits on liver cells and pulls LDL particles out of circulation. When this receptor doesn’t work properly or isn’t produced in sufficient numbers, LDL accumulates in the blood.
Mutations in two other genes also cause FH. One affects apolipoprotein B, a protein on the surface of LDL particles that the receptor needs to recognize and grab onto. The other involves PCSK9, a protein that normally breaks down LDL receptors. Gain-of-function mutations in PCSK9 cause receptors to be destroyed too quickly, leaving fewer available to clear cholesterol. People who inherit a defective gene from one parent (heterozygous FH) typically have LDL levels between 190 and 400 mg/dL. Those who inherit defective copies from both parents (homozygous FH) can have LDL above 500 mg/dL and may develop heart disease in childhood.
The non-inherited form develops from a combination of diet high in saturated fat, physical inactivity, obesity, and aging. Certain medical conditions like hypothyroidism and kidney disease can also push LDL levels up. In practice, many people have a mix of genetic susceptibility and lifestyle factors working together.
How High LDL Damages Arteries
The danger of sustained high LDL isn’t the cholesterol circulating in your blood. It’s what happens when LDL particles cross into the walls of your arteries. Once inside, they get trapped by structural proteins in the artery lining and undergo chemical changes, particularly oxidation. These modified LDL particles trigger an immune response. White blood cells called monocytes migrate into the artery wall, mature into macrophages, and begin swallowing the modified cholesterol. Because these immune cells can’t regulate how much cholesterol they absorb, they become engorged, turning into what pathologists call foam cells.
Foam cells are the building blocks of arterial plaque. As they accumulate, they form fatty streaks visible even in young adults. Over time, smooth muscle cells migrate into the area and produce a fibrous cap over the fatty deposit. This cap protects the vessel wall, but it also narrows the artery. The real crisis comes when a plaque’s cap thins out, weakened by enzymes released from the inflammatory cells packed inside. A thin-capped plaque can rupture, exposing its contents to the bloodstream and triggering a blood clot that can block the artery entirely. In a coronary artery, that’s a heart attack. In a brain artery, it’s a stroke.
This process typically produces symptoms in the general population around age 55 to 65. For people with familial hypercholesterolemia, the timeline accelerates dramatically. Without treatment, half of men with FH will have a heart attack by age 50, and 30% of women with FH will have one by age 60.
Physical Signs to Recognize
Most people with high cholesterol have no visible symptoms, which is why screening blood tests matter. But pure hypercholesterolemia, particularly the familial form, can produce distinctive physical signs that sometimes appear before a person ever gets a cholesterol panel done.
Xanthomas are the most characteristic. These are yellow papules, plaques, or firm nodules that form when cholesterol-laden foam cells deposit in soft tissue. Tendon xanthomas, which feel like firm lumps under the skin over the Achilles tendon, kneecap tendon, or hand tendons, are considered a classic marker of FH. Eruptive xanthomas can also appear on the trunk, buttocks, and outer surfaces of the arms and legs. Xanthelasma, flat yellowish deposits around the eyelids, is another common sign.
A grayish-white ring around the outer edge of the cornea, called corneal arcus, results from lipid depositing in the deep layers of the cornea. While corneal arcus is relatively common in older adults and not necessarily alarming, its presence in someone under 45 is a strong signal of underlying lipid abnormality. In children or teenagers, the appearance of xanthomas or corneal arcus should prompt immediate cholesterol testing, as it may indicate the severe homozygous form of FH.
How It’s Treated
Treatment has two layers: lifestyle changes and medication. For everyone with pure hypercholesterolemia, dietary adjustments form the foundation. The primary target is saturated fat. Current guidelines recommend keeping saturated fat below 10% of daily calories, which works out to roughly 20 grams per day on a 2,000-calorie diet. Replacing saturated fats (from red meat, butter, cheese, and coconut oil) with unsaturated fats (from olive oil, nuts, avocados, and fatty fish) directly lowers LDL. Increasing soluble fiber from oats, beans, and fruits also helps by binding cholesterol in the gut before it enters the bloodstream. Regular aerobic exercise and maintaining a healthy weight provide additional, modest LDL reductions.
For most people with significantly elevated LDL, lifestyle changes alone won’t be enough. Statin medications are the first-line drug therapy and remain the most thoroughly studied cholesterol treatment available. They work by blocking an enzyme the liver needs to produce cholesterol, which forces the liver to pull more LDL out of the bloodstream. For people with LDL at or above 190 mg/dL, guidelines call for the highest tolerated statin dose. For those with diabetes between ages 40 and 75, moderate-intensity statin therapy is the starting point, with higher doses recommended as additional risk factors develop.
When statins alone don’t bring LDL to goal, or when someone can’t tolerate them, additional options exist. Cholesterol absorption blockers prevent the intestine from absorbing dietary and bile cholesterol. A newer class of injectable medications targets the PCSK9 protein, the same one involved in some genetic forms of FH. By blocking PCSK9, these drugs allow more LDL receptors to survive on liver cells, pulling more cholesterol from the blood. One such injectable, given just twice a year, reduced LDL by approximately 50% in large clinical trials. This is a meaningful option for people with familial hypercholesterolemia or those who haven’t reached their targets with oral medications.
Why Early Detection Changes Outcomes
The cardiovascular damage from pure hypercholesterolemia is cumulative. Every year of elevated LDL adds to the total cholesterol exposure your arteries absorb. This is why someone with FH who has had high LDL since birth faces a dramatically different risk profile than someone whose cholesterol climbed gradually in middle age, even if their current numbers look identical. Cardiologists sometimes refer to this as the “cholesterol-year” burden, similar to how pack-years measure smoking exposure.
Screening guidelines recommend that all adults have their cholesterol checked starting at age 20, with repeat testing every four to six years if levels are normal. Children with a family history of early heart disease or known FH should be screened between ages 2 and 10. Catching familial hypercholesterolemia early and starting treatment in childhood or adolescence can reduce coronary artery disease risk by about 80%, essentially normalizing what would otherwise be one of the highest-risk conditions in cardiovascular medicine.